Get the Stockscreener App
1.32
1.54%
0.02
After Hours:
1.28
-0.04
-3.03%
Boundless Bio Inc stock is traded at $1.32, with a volume of 391.85K.
It is up +1.54% in the last 24 hours and up +14.78% over the past month.
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
See More
Previous Close:
$1.30
Open:
$1.27
24h Volume:
391.85K
Relative Volume:
3.88
Market Cap:
$29.55M
Revenue:
-
Net Income/Loss:
$-64.39M
P/E Ratio:
-0.4571
EPS:
-2.8877
Net Cash Flow:
$-56.24M
1W Performance:
+7.32%
1M Performance:
+14.78%
6M Performance:
+6.45%
1Y Performance:
-56.29%
1-Day Range:
$1.24
$1.444
1-Week Range:
$1.23
$1.444
52-Week Range:
$1.00
$3.75
Boundless Bio Inc Stock (BOLD) Company Profile
Name
Boundless Bio Inc
Sector
Industry
Phone
(858) 766-9912
Address
10955 ALEXANDRIA WAY, SAN DIEGO
Compare BOLD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BOLD
Boundless Bio Inc
|
1.32 | 29.10M | 0 | -64.39M | -56.24M | -2.8877 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| May-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-13-24 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-22-24 | Initiated | Guggenheim | Buy |
| Apr-22-24 | Initiated | Leerink Partners | Outperform |
| Apr-22-24 | Initiated | Piper Sandler | Overweight |
View All
Boundless Bio Inc Stock (BOLD) Latest News
Detecting support and resistance levels for Boundless Bio Inc.Market Weekly Review & Weekly Stock Performance Updates - newser.com
Can Boundless Bio Inc. stock sustain institutional interestPortfolio Value Report & Stock Portfolio Risk Control - newser.com
How to build a dashboard for Boundless Bio Inc. stockNew Guidance & AI Driven Stock Movement Reports - newser.com
Heatmap analysis for Boundless Bio Inc. and competitorsPortfolio Risk Summary & Safe Entry Trade Signal Reports - newser.com
How Boundless Bio Inc. stock valuations compare to rivals2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Is Boundless Bio Inc. stock positioned for digital transformationTrade Ideas & Detailed Earnings Play Alerts - newser.com
Will Boundless Bio Inc. stock go up soonSwing Trade & Reliable Intraday Trade Alerts - newser.com
Boundless Bio to Present Research on Novel Cancer Therapeutics at AACR-NCI-EORTC Conference 2025 - Quiver Quantitative
Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - MarketScreener
Oct 23 Poster: BBI-825 + BBI-355 synergy — Boundless Bio at AACR-NCI-EORTC 2025 in Boston - Stock Titan
Can Boundless Bio Inc. stock outperform in 2025 bull market2025 Market Sentiment & Fast Moving Stock Trade Plans - newser.com
Is Boundless Bio Inc. stock a buy for dividend growthJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com
What to expect from Boundless Bio Inc. in the next 30 daysWeekly Trade Review & High Win Rate Trade Alerts - newser.com
Real time pattern detection on Boundless Bio Inc. stockQuarterly Profit Report & Weekly High Conviction Ideas - newser.com
Custom strategy builders for tracking Boundless Bio Inc.2025 Trading Recap & Weekly Watchlist for Hot Stocks - newser.com
Analyzing recovery setups for Boundless Bio Inc. investorsJuly 2025 Big Picture & Technical Pattern Recognition Alerts - newser.com
Visualizing Boundless Bio Inc. stock with heatmapsTrade Volume Report & AI Powered Buy/Sell Recommendations - newser.com
Fierce Biotech Layoff Tracker 2025: Ascidian Tx trims team; Ferring plots 500 layoffs - Fierce Biotech
Checkpoint Inhibitors Competitive Landscape Report 2025: - openPR.com
Using AI based signals to follow Boundless Bio Inc.2025 Volatility Report & Community Shared Stock Ideas - newser.com
What indicators show strength in Boundless Bio Inc.July 2025 Volume & Community Consensus Stock Picks - newser.com
Using flow based indicators on Boundless Bio Inc.Quarterly Earnings Summary & Short-Term High Return Strategies - newser.com
What Analysts’s Earnings Revisions Mean for Aristo Bio StockMarket Liquidity Analysis & Small Entry Cost Stocks - earlytimes.in
Is Boundless Bio Inc a good long term investmentGlobal Market Influence & Big Data Market Reports - earlytimes.in
Institutional scanner results for Boundless Bio Inc.Market Sentiment Report & Technical Analysis for Trade Confirmation - newser.com
How to interpret RSI for Boundless Bio Inc. stockQuarterly Trade Summary & High Win Rate Trade Tips - newser.com
How Regulatory Changes Could Impact SSPDL Limited’s BusinessContrarian Investment Ideas & Stay Invested. Stay Smart. - earlytimes.in
What MACD signals say about Boundless Bio Inc.July 2025 Momentum & Low Drawdown Momentum Ideas - newser.com
Layoff Tracker: CSL Vifor, Bolt Cut Staff - BioSpace
Pattern recognition hints at Boundless Bio Inc. upside2025 Trading Volume Trends & Precise Trade Entry Recommendations - newser.com
How Hampton Sky Realty Limiteds Balance Sheet Supports LongTerm GrowthReal-Time Stock Alerts & Small Entry Cost Portfolio - earlytimes.in
CPAY Stock Analysis and ForecastMid Cap Growth Trends & These 3 Stocks Could Change Your Portfolio - earlytimes.in
Boundless Bio Inc Stock Analysis and ForecastEarnings Forecast Updates & Follow Top Performers in the Community - earlytimes.in
Boundless Bio Inc Stock (BOLD) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):